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Abnormal vascular architecture at the
placental-maternal interface in preeclampsia 
Introduction
Preeclampsia (PE) is a pregnancy-associated disorder and 
a multisystem disease characterized by the sudden onset of hy-
pertension associated with either proteinuria or end-organ dys-
function after 20 weeks of gestation in women with no previous 
history of hypertension. PE is one of the most important causes 
of maternal and perinatal morbidity and mortality, with PE-re-
lated deaths estimated to amount to 50,00-60,000 per year. The 
incidence of PE has increased by 25% in the United States over 
the past two decades [1].
The clinical manifestations are caused by mild to severe 
microangiopathy of different organs [2]. Hepatic or renal failure, 
pulmonary edema, cardiovascular disease and death are the po-
tential maternal sequelae. On the fetal side, potential conse-
quences of PE are late miscarriage, retro-placental hematoma, 
fetal growth restriction (FGR), hypoxic neurologic injury and 
in utero fetal death. These fetal and neonatal consequences re-
sult from placental hypoperfusion.
Several genetic, immunologic, physiological, environmen-
tal, demographic and pregnancy-associated factors have been 
associated with the occurrence of PE. These include: multiple 
pregnancy, maternal age at the extremes of the fertile range, 
personal and family history of PE, obesity, ethnic group, egg 
donation, chronic hypertension, renal disease, metabolic dis-
ease and thrombophilia [3, 4]. 
Although the etiology of PE has not been completely elu-
cidated, the placenta plays a central role in the development of 
this disease. The prevailing view, supported by epidemiologic 
and experimental data, is that PE is due largely to a defect in 
trophoblast invasion and the remodeling of the uterine spiral 
arteries [5]. It results in impaired placentation in the first tri-
mester of pregnancy, leading to inadequate placental perfusion 
in the second and third trimesters [6]. This process leads to an 
imbalance between pro-angiogenic and anti-angiogenic fac-
tors, released by the placenta into the maternal circulation, that 
causes systemic endothelial dysfunction [7]. However, a precise 
definition of the vascular architecture at the placental-maternal 
interface is lacking in women with PE. 
The aim of this study was to characterize the vascular ar-
chitecture in the placental bed in pregnancies complicated by 
PE and in normal pregnancies, applying our previously pub-
lished method consisting of high-resolution virtual imaging of 
whole-tissue sections and computer-assisted image analysis of 
the placental bed of PE patients and controls [8].
Methods
Tissue collection
The American College of Obstetricians and Gynecologists 
(ACOG) defines PE as the onset, after 20 weeks of amenorrhea, 
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Vessel architecture in preeclampsia
of hypertension (≥ 140/90) associated with proteinuria and/or 
single or multiple organ involvement [9]. Placental bed biopsies 
were obtained prospectively from 11 patients presenting PE 
and from 10 women presenting uncomplicated pregnancies and 
delivered by elective cesarean section for breech presentation, 
feto-pelvic disproportion or a history of two previous cesarean 
sections. All these biopsies were sampled under direct vision 
by the same operator (F.C.); samples were obtained after pla-
cental delivery from the central zone of the placental site apply-
ing the previously described knife technique [10,11]. Adequacy of 
the samples was controlled by analysis of hematoxylin-eosin–
stained sections. Only areas in which myometrium was present 
were analyzed. These placental bed biopsies were analyzed by 
two operators (F.C. and J.T.).
Histology and immunohistochemistry
All biopsies were fixed in 4% formaldehyde in phosphate-buff-
ered saline (PBS) and embedded in paraffin. Immunohisto-
chemistry for CD31 (vascular endothelial cell marker) was 
performed on 4-μm thick paraffin sections that were mounted 
on aminopropyltriethoxysilane (Tespa)-coated glass slides.
The sections were dewaxed in xylene and rehydrated. An-
tigen retrieval was achieved using Target Retrieval Solution 
(S2031; DakoCytomation, Glostrup, Denmark). Endogenous 
peroxidases were blocked by incubation in 3% H2O2 for 20 
minutes, and nonspecific binding was prevented by incuba-
tion in PBS/normal goat serum. Sections were incubated with 
monoclonal anti-CD31 (M0823, 1:40; DakoCytomation) for 
60 minutes at 37°C and then biotinylated goat antimouse IgG 
(E0433, 1:400; DakoCytomation), followed by streptavidin/
horseradish peroxidase (P0397, 1:500; DakoCytomation).
Labeling was visualized with 3-3-diaminobenzidine hy-
drochloride (K3468; DakoCytomation) as the chromogen and 
hematoxylin as the counterstain. Nonspecific binding of prima-
ry antibody was evaluated using mouse IgG1 at the same im-
munoglobulin concentration as the primary antibody (X0931; 
DakoCytomation).
Image acquisition, processing, and measurements
Virtual images of the whole tissue sections were acquired us-
ing the fully automated digital microscopy system dot-Slide 
(BX51TF; Olympus, Aartselaar, Belgium) coupled with a 
Peltier-cooled, high-resolution digital color camera (XC10; 
Olympus) at a resolution of 1376 x 1032 pixels. Whole-tissue 
sections at high magnification (x100) were scanned, yielding 
virtual images with a 0.65 μm pixel size.
The vessel parameters were characterized in the myome-
trium located under the placental-myometrial junction. Bina-
ry images were decimated before quantification, according to 
a previously described procedure because the original virtual 
images exceeded several gigabytes. CD31-identified endothe-
lial cells allowed automatic computerized acquisition of blood 
vessel characteristics. Vessel area density was defined as the 
number of pixels belonging to all vessels (endothelium and en-
compassed lumen, i.e., the total area occupied by vessels) di-
vided by the total number of pixels of the myometrial area. The 
number of vessel cross-sections per unit area was defined as 
the number of vessels divided by the area of myometrium. The 
area of each vessel cross-section was measured, and the vessel 
cross-section area distribution was plotted as a histogram. Im-
age processing and measurements were performed using MAT-
LAB version 9.2 software (MathWorks, Natick, MA). 
Statistical analysis 
The results are expressed as means ± 95% CI of individually 
tested parameters (vessel area density, number of vessels/unit 
area, area of individual vessel sections, vessel cross-section 
area distribution, and distance from each vessel to the placen-
tal-myometrial junction) (Table 1). For each parameter, a large 
number of measurements was performed in each individual 
(mean number of vessels per tissue section, 3385 ± 850.8 for 
PE cases and 2863 ± 466.5 for control cases). Tests of homoge-
neity performed in each group (PE and control) confirmed the 
homogeneity of both populations for the evaluated parameters. 
It can therefore be concluded that for the tested parameters, 
the PE and the control group displayed homogenous charac-
teristics. The statistical differences between the groups were 
assessed using the nonparametric Mann-Whitney U test. Fur-
thermore, we used the nonparametric Kolmogorov-Smirnov 
test for distributions and analysis of covariance for linear re-
gressions. P < 0.05 defined significance. Statistical analyses 
were performed with MATLAB version 9.2 software.
Results
Table 2 summarizes the demographic and obstetric charac-
teristics of the PE patients and controls. There was no signifi-
cant difference in gravidity and parity between the two groups. 
As expected, women with PE had higher blood pressure and 
abnormal proteinuria. Furthermore, the women with PE deliv-
ered significantly earlier than the controls.
Table 1 
VESSEL SURFACE DENSITY NUMBER OF SECTIONS AVERAGE SURFACE
CT PE CT PE CT PE
Mean 0,09694 0,06079 80,13 64,9 0,001453 0,000962
SD 0,05303 0,01903 50,54 16,03 0,000662 0,000309
SEM 0,01677 0,005738 15,98 4,833 0,000209 9,31E-05
Lower 95% CI of mean 0,05901 0,04801 43,98 54,14 0,00098 0,000754
Upper 95% CI of mean 0,1349 0,07358 116,3 75,67 0,001927 0,001169
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Figure 1 Illustration of the computer-assisted image analysis of vessels in control sections (A-C) and PE sections (D-F). A and D, representative 
CD31-positive immunolabeled vessels. B and E, binarized images generated from from immunolabeled sections. C and F, selected zones at higher 
magnification. Figure 1G shows a close up of the CD31 staining.
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Figure 1 illustrates the computer-assisted image algorithm 
for a control and a PE case. On the whole-slide section most 
vessels were automatically detected, whereas some missed ves-
sels and the limits of tissue section were manually corrected. 
Figure 1 (B and E) shows binarized images, subsequently used 
for vascular architecture characterization.
Placental bed vessel characteristics
The mean number of vessels per tissue section was similar in 
the control and PE groups (80.13 ±0.13 vessels/mm2 vs 64.90 
± 4.83 vessels/mm2, P= 0.8053, figure 2A). However, in the 
PE group the cross-sectional vessel areas were reduced com-
pared with what was observed in the control group (0.0608 ± 
0.0057 vs 0.0969 ± 0.0168, P= 0.0378, figure 2B). The sur-
face occupied by blood vessels was determined and found to be 
slightly reduced in PE (0.0962 10-3 ± 0.0932 10-3 vessels/mm2 
vs 1.453 10-3 ± 0.294 10-3 vessels/mm2, P=0.0620, figure 2C). 
To confirm this, the log10 –transformed vessel size distribution 
was analyzed (Figure 2D). This normalized histogram indeed 
highlights the presence of smaller vessels in PE.
 
Discussion
In this study, we compare the vessel organization in the 
placental bed of PE cases compared with the placental bed in 
normal pregnancy applying a method previously used by our 
workgroup to describe vascular characteristics in early inva-
sive cervical cancer and placenta increta [8,12]. This method 
combines the use of a high-resolution virtual imaging system 
on whole-tissue sections with the use of computer-assisted im-
age analysis of whole-slide CD31-immunolabeled sections. 
Through this method, we demonstrated and confirmed that 
more smaller vessels are present in PE placental beds com-
pared with normal placental beds.
PE is a complex disorder with a large range of clinical pres-
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Table 1 Demographic and obstetrical characteristics.
VARIABLE CONTROLS (N=10) PREECLAMPSIA (N=11) P VALUE
Maternal age at delivery (years)a 29 (20- 42) 28 (23- 38) NS
Gestational age at delivery (weeks)a 38.5 (32.7-39) 32 (25.3- 37.1) 0,00003
Graviditya 3 (1-8) 3 (1-6) NS
Paritya 2 (0-7) 1 (0-2) NS
HELLP 0/10 3/11
Proteinuria 0/10 10/11
Systolic BP (mmHg) 121 (101-155) 145 (125-185) 0,021
Diastolic BP (mmHg) 72.8 (62-105) 88.18 (71-105) 0,032
Birth weight (g) 3240 (1660-3838) 1540 (480- 2258) 0,0004
NS, not significant. a Data presented are expressed in medians (minimum-maximum) and analyzed with the Mann-Whitney U test 
G
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Figure 2 A, Mean number of vessels per cross-section. B, Vessel area density. C, Mean vessel cross-section area. D, Histogram of the normalized 
frequency of vessels versus vessel cross-section area distribution (log10 scale). 
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entations. This heterogeneity suggests the possible existence of 
various pathogenic mechanisms. It is well known that PE is 
associated with poor placentation and incomplete remodeling 
of the utero-placental spiral arteries [13].
Despite extensive study of the pathogenesis of PE, the ex-
act vascular architecture of the placental bed in PE is unclear. 
As regards the placenta, increased villous capillary branching 
has been reported in placentas from PE versus normal term 
pregnancies [14]. In contrast, other investigators have reported 
decreased micro-vessel counts in PE placentas [5, 15, 16] or un-
changed vascular densities between PE and normal term pla-
centas [17, 18]. As early as 1985, Las Heras et al. showed a signif-
icant reduction in the ratio of lumen-to-whole-diameter of the 
fetal arteries in “toxemia” as compared with normal pregnancy 
and acute fetal distress groups [19]. Moreover, they showed that 
the mean lumen-to-whole-diameter ratio also differed between 
regions of the placenta in all groups, the most marked reduc-
tion being in the parachorial region and the least prominent 
reduction in the parabasal zone. Finally, they found no signifi-
cant differences in the mean diameter ratio between three sub-
groups of the toxemic pregnancies (PE, essential hypertension 
and renal disease groups).
More recently, Uras et al. evaluated placentas of PE cases 
by using immuno-histochemical staining with CD31 and with 
Factor VIII antibodies. When the PE and control groups were 
compared, CD31 and Factor VIII staining were significantly 
lower in the PE group. This study indirectly suggests that the 
balance between proangiogenic and antiangiogenic factors is 
shifted in favor of anti-angiogenic factors in PE [15].
In 2013, Lyall et al. demonstrated the occurrence of a 
major defect in myometrial spiral artery remodeling in PE [5]. 
In this study, placental bed biopsies were immuno-stained to 
determine vessel wall integrity, extravillous cytotrophoblast 
location/density, periarterial fibrinoid, and endothelium. The 
authors compared normal pregnancies and pregnancies com-
plicated by PE or severe FGR and they examined spiral artery 
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remodeling and extravillous cytotrophoblast density. The inva-
sion of vessel wall smooth muscle was reduced in myometrial 
spiral arteries in PE and FGR groups compared with controls. 
Although failure to destroy myometrial vessel wall smooth 
muscle is a feature of PE, 10% of decidual vessels in PE also 
retained their muscle wall. Moreover, interstitial extravillous 
cytotrophoblast density seems to be similar in normal preg-
nancy and PE and the normal group showed more intramural 
extravillous cytotrophoblasts than the PE group. This work 
suggests that lack of intramural trophoblasts in the myometri-
al vessels rather than defective interstitial trophoblast invasion 
may be the primary abnormality in PE [20]. In our study, we 
focused on the size and the areas occupied by vessels. We did 
not perform detailed analysis of the histologic appearance of 
the different vessels in the placenta beds.
Possible limitations of this study are the small sample size 
and the two-observer analysis. Moreover, another possible lim-
itation is the difficulty in collecting gestational age matched 
bed biopsies from normal pregnancies as controls. However, 
the median 5-week difference in gestational length between our 
groups should not drastically affect vessel size and distribution 
in the placental bed. We chose patients undergoing elective 
term cesarean section deliveries as the control group in order 
to obtain placental bed biopsies of good quality and to avoid 
the bias of impaired placentation in earlier deliveries often in-
dicated for pregnancies complicated by PE, intrauterine growth 
restriction (IUGR) or premature rupture of membranes. 
This study confirms previously published data on placen-
tal bed abnormality in pregnancies complicated by PE. In this 
clinical situation, vessels are smaller in size, which can explain 
the under-perfusion of the placenta. Compared with manual or 
stereotaxic methods, the automated detection of CD31-stained 
histologic sections used in this study allows easier and probably 
more precise measurement of the number and size of vessels.
Conclusion
Through whole slide scanning and computer-assisted anal-
ysis, we revealed a different morphological architecture of ves-
sels in the placental bed in PE. This might reflect the insuffi-
cient trophoblast invasion and incomplete vascular remodeling 
previously described by others.
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